What is Excite Pharma Services?
Headquartered in Lees Summit, Missouri, Excite Pharma Services operates as a critical infrastructure partner for the global pharmaceutical industry. By providing comprehensive CDMO and CRO capabilities, the company bridges the gap between drug discovery and commercial-scale production. Their service model is anchored in rigorous adherence to FDA, cGMP, and GLP standards, ensuring that pharmaceutical clients can navigate complex regulatory landscapes with confidence. The company's expertise in chemistry services and manufacturing compliance positions it as a vital link in the drug development supply chain, catering to firms that require precision, reliability, and technical excellence in their outsourced operations.
How much funding has Excite Pharma Services raised?
Excite Pharma Services has raised a total of $461K across 2 funding rounds:
Debt
$150K
Debt
$311K
Debt (2020): $150K with participation from PPP
Debt (2021): $311K led by PPP
Key Investors in Excite Pharma Services
PPP
Public-Private Partnership
What's next for Excite Pharma Services?
With the successful acquisition of $311K, Excite Pharma Services is well-positioned to accelerate its late-stage growth strategy. The capital is expected to facilitate the expansion of its manufacturing footprint and the enhancement of its research infrastructure to meet the rising demand for specialized pharmaceutical outsourcing. As the industry continues to prioritize supply chain resilience and regulatory compliance, Excite Pharma is likely to leverage this investment to deepen its service offerings and potentially explore new therapeutic modalities. The strategic focus will remain on maintaining high-quality standards while scaling operations to support a broader portfolio of global pharmaceutical partners, effectively transitioning from a regional player to a more prominent entity in the international CDMO/CRO landscape.
See full Excite Pharma Services company page
